These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 29470821

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Head-to-Head Comparison of EQ-5D-3L and EQ-5D-5L Health Values.
    Selivanova A, Buskens E, Krabbe PFM.
    Pharmacoeconomics; 2018 Jun; 36(6):715-725. PubMed ID: 29623559
    [Abstract] [Full Text] [Related]

  • 3. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
    Law EH, Pickard AS, Xie F, Walton SM, Lee TA, Schwartz A.
    Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
    Jin X, Al Sayah F, Ohinmaa A, Marshall DA, Smith C, Johnson JA.
    Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
    [Abstract] [Full Text] [Related]

  • 7. EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.
    Gandhi M, Ang M, Teo K, Wong CW, Wei YC, Tan RL, Janssen MF, Luo N.
    Patient; 2019 Aug; 12(4):383-392. PubMed ID: 30607809
    [Abstract] [Full Text] [Related]

  • 8. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
    Feng Y, Devlin N, Herdman M.
    Health Qual Life Outcomes; 2015 Oct 21; 13():171. PubMed ID: 26489956
    [Abstract] [Full Text] [Related]

  • 9. A head-to-head comparison of measurement properties of the EQ-5D-3L and EQ-5D-5L in acute myeloid leukemia patients.
    Yu H, Zeng X, Sui M, Liu R, Tan RL, Yang J, Huang W, Luo N.
    Qual Life Res; 2021 Mar 21; 30(3):855-866. PubMed ID: 32965633
    [Abstract] [Full Text] [Related]

  • 10. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D.
    Feng Y, Herdman M, van Nooten F, Cleeland C, Parkin D, Ikeda S, Igarashi A, Devlin NJ.
    Qual Life Res; 2017 Aug 21; 26(8):2067-2078. PubMed ID: 28343350
    [Abstract] [Full Text] [Related]

  • 11. Is EQ-5D-5L Better Than EQ-5D-3L Over Time? A Head-to-Head Comparison of Responsiveness of Descriptive Systems and Value Sets from Nine Countries.
    Janssen MF, Buchholz I, Golicki D, Bonsel GJ.
    Pharmacoeconomics; 2022 Nov 21; 40(11):1081-1093. PubMed ID: 35930137
    [Abstract] [Full Text] [Related]

  • 12. Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?
    Yang F, Devlin N, Luo N.
    Value Health; 2019 Jan 21; 22(1):45-49. PubMed ID: 30661633
    [Abstract] [Full Text] [Related]

  • 13. Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys.
    Martí-Pastor M, Pont A, Ávila M, Garin O, Vilagut G, Forero CG, Pardo Y, Tresserras R, Medina-Bustos A, Garcia-Codina O, Cabasés J, Rajmil L, Alonso J, Ferrer M.
    Popul Health Metr; 2018 Aug 16; 16(1):14. PubMed ID: 30115092
    [Abstract] [Full Text] [Related]

  • 14. Transitioning between the EQ-5D youth and adult descriptive systems in a group of adolescents.
    Verstraete J, Kind P, Janssen MF, Yang Z, Stolk E, Gebregziabiher A.
    J Patient Rep Outcomes; 2024 Aug 12; 8(1):93. PubMed ID: 39133433
    [Abstract] [Full Text] [Related]

  • 15. Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China.
    Weng G, Hong Y, Luo N, Mukuria C, Jiang J, Yang Z, Li S.
    Eur J Health Econ; 2023 Mar 12; 24(2):197-207. PubMed ID: 35538178
    [Abstract] [Full Text] [Related]

  • 16. Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China.
    Jiang J, Hong Y, Zhang T, Yang Z, Lin T, Liang Z, Lu P, Liu L, Wang B, Xu Y, Luo N.
    Qual Life Res; 2021 Jul 12; 30(7):2045-2060. PubMed ID: 33821418
    [Abstract] [Full Text] [Related]

  • 17. Validity of EQ-5D-5L in stroke.
    Golicki D, Niewada M, Buczek J, Karlińska A, Kobayashi A, Janssen MF, Pickard AS.
    Qual Life Res; 2015 Apr 12; 24(4):845-50. PubMed ID: 25347978
    [Abstract] [Full Text] [Related]

  • 18. Evaluating equivalency between response systems: application of the Rasch model to a 3-level and 5-level EQ-5D.
    Pickard AS, Kohlmann T, Janssen MF, Bonsel G, Rosenbloom S, Cella D.
    Med Care; 2007 Sep 12; 45(9):812-9. PubMed ID: 17712251
    [Abstract] [Full Text] [Related]

  • 19. Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients.
    Khan I, Morris S, Pashayan N, Matata B, Bashir Z, Maguirre J.
    Health Qual Life Outcomes; 2016 Apr 12; 14():60. PubMed ID: 27072351
    [Abstract] [Full Text] [Related]

  • 20. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study.
    Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J.
    Qual Life Res; 2013 Sep 12; 22(7):1717-27. PubMed ID: 23184421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.